Recent developments of liposomes as nanocarriers for theranostic applications

Hang Xing, Kevin Hwang, Yi Lu

Research output: Contribution to journalReview article

Abstract

Liposomes are nanocarriers comprised of lipid bilayers encapsulating an aqueous core. The ability of liposomes to encapsulate a wide variety of diagnostic and therapeutic agents has led to significant interest in utilizing liposomes as nanocarriers for theranostic applications. In this review, we highlight recent progress in developing liposomes as nanocarriers for a) diagnostic applications to detect proteins, DNA, and small molecule targets using fluorescence, magnetic resonance, ultrasound, and nuclear imaging; b) therapeutic applications based on small molecule-based therapy, gene therapy and immunotherapy; and c) theranostic applications for simultaneous detection and treatment of heavy metal toxicity and cancers. In addition, we summarize recent studies towards understanding of interactions between liposomes and biological components. Finally, perspectives on future directions in advancing the field for clinical translations are also discussed.

Original languageEnglish (US)
Pages (from-to)1336-1352
Number of pages17
JournalTheranostics
Volume6
Issue number9
DOIs
StatePublished - Jan 1 2016

Keywords

  • Clinical translation
  • Liposomes
  • Multimodal imaging
  • Targeted therapy
  • Theranostics

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Fingerprint Dive into the research topics of 'Recent developments of liposomes as nanocarriers for theranostic applications'. Together they form a unique fingerprint.

  • Cite this